Form 4 for CYTK CYTOKINETICS INC
Accepted 2022-08-08 00:00:00 ET · period of report 2022-08-05 · accession 0001127602-22-020670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-08 | 2022-08-05 | CYTK | Kaye Edward M. MD | Dir | S - Sale+OE | $50.00 | -11.4K | 12.6K | -48% | -$571.4K |
| D | 2022-08-08 | 2022-08-05 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $8.75 | +11.4K | 24.0K | +91% | +$100.0K |
| D | 2022-08-08 | 2022-08-05 | CYTK | Kaye Edward M. MD | Dir | M - OptEx | $0.00 | -11.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-05 | S | D | 11,428 | $50.00 | 12,576 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-05 | M | A | 11,428 | $8.75 | 24,004 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2022-08-05 | M | D | 11,428 | $0.00 | 0 | D | $8.75 · 2018-02-02 to 2028-01-02 | 11,428 Common Stock |